Bizcap, a leading provider of fast and flexible business loans, has announced its launch into Luxembourg, establishing its first operational footprint in continental Europe. The move signals Bizcap's commitment to empowering small and medium-sized enterprises (SMEs) across the globe with fast, flexible, and transparent financing. Founded in Australia, Bizcap has established itself across Australia and […]

Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team Egham, UK – 03 July 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the appointment of Simon Ramsden as Chief Financial Officer and Rob Smith as

Drug candidate is one of several oncology assets approaching or in clinical development, discovered through Oxford BioTherapeutics' proprietary OGAP(R)-Verify discovery platform OBT receives milestone payment associated with advance of drug candidate Oxford, UK and San Jose, California, 3 July 2025 – Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (IO)

Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team GlobeNewswire July 03, 2025 Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team Egham, UK – 03 July 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients

Oxford BioTherapeutics Announces Third Oncology Drug Candidate from Boehringer Ingelheim Collaboration Selected to Advance into IND-Enabling Studies GlobeNewswire July 03, 2025 Drug candidate is one of several oncology assets approaching or in clinical development, discovered through Oxford BioTherapeutics' proprietary OGAP(R)-Verify discovery platform OBT receives milestone payment associated with advance of drug candidate Oxford, UK and

Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a bispecific Antibody-Drug Conjugate (ADC) targeting Trop2 and Nectin4. AK146D1 is Akeso's first bispecific ADC to enter clinical trials. AK146D1 has recently received approval from the U.S. FDA, Australia's TGA, and

The Volvo Group report for the second quarter 2025 will be published on July 17, at 7.20 a.m.CEST. There will be a conference call for press and analysts starting at 9.00 a.m. CEST. An online presentation of the report, followed by a question-and-answer session, will be broadcasted at 9.00 a.m. CEST. The Volvo Group will

LAKE LEELANAU, Mich., July 03, 2025 (GLOBE NEWSWIRE) — How do I know if land is buildable? This is a question many prospective buyers ask when exploring property along Lake Leelanau's scenic shoreline. In an expert article featured in HelloNation, Sander Scott of Net Real Estate outlines what to check before buying waterfront property to

SUMNER, Wash., July 03, 2025 (GLOBE NEWSWIRE) — What drives long-term employee loyalty in the automotive sector–compensation packages or company culture? According to a featured article in HelloNation, businesses that lead with mentorship, shared values, and team cohesion foster stronger retention and more sustainable careers. Phil Mitchell of Sunset Auto Family in Sumner, Washington, explains

Real Estate Agent Sander Scott of Net Real Estate Shares Insights as Waterfront Lot Expert in HelloNation GlobeNewswire July 03, 2025 LAKE LEELANAU, Mich., July 03, 2025 (GLOBE NEWSWIRE) — How do I know if land is buildable? This is a question many prospective buyers ask when exploring property along Lake Leelanau's scenic shoreline. In